Zonagen, Inc. (Nasdaq:ZONA)(PCX:ZONA), a biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive...
Zonagen, Inc. (Nasdaq:ZONA)(PCX:ZONA) today reported financial results for the three-month and nine-month periods ended September 30, 2005 and...
Zonagen, Inc. (NASDAQ:ZONA) announced today that the Company's President and CEO, Joseph Podolski, will present a corporate overview on Wednesday...
-Zonagen, Inc. (Nasdaq:ZONA) (PCX:ZONA) today announced that the Company has awarded contracts for its next planned US studies for both...
Zonagen, Inc. (NasdaqSC: ZONA) will present at the following forum: ? What: Informed Investors Biotechnology / Healthcare / Pharmaceutical...
Zonagen, Inc. (Nasdaq:ZONA)(PCX:ZONA) today provided an overview of the status of its Progenta(TM) and Androxal(TM) clinical programs, reported...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.